Navigation Links
Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
Date:6/29/2011

LAS VEGAS and NEWARK, N.J., June 29, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today it has entered into agreement with Horizon Healthcare Services, Inc., headquartered in Newark, New Jersey, to offer the storage of umbilical cord blood to its members. Under this agreement, members of Horizon Healthcare Services, Inc. will receive a discount on storage services compared to what Cord Blood America charges its other first-time customers.

"We are pleased that CorCell, our United States brand, can collaborate with Horizon Healthcare Services, Inc. and offer these important, potentially life-saving services, to its 3.6 million members.  We will also be offering courses to nurses and other healthcare professionals to help them counsel their patients on the value of stem cell storage," said Matthew Schissler, CEO and co-founder.

"We are focused on organic growth for CBAI.  Horizon Healthcare Services, Inc. is extremely important to us, and we look forward to educating the medical community and New Jersey families on  the regenerative importance of cord blood stem cells, while offering a discount because of our relationship," continued Mr. Schissler.

Cord blood stem cells are used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies, while research is ongoing to determine the usefulness of stem cells in combating some of the nation's most serious diseases, including diabetes, heart disease, Parkinson's and other diseases for which there is currently no cure.

About Horizon Healthcare Services, Inc.

Horizon Healthcare Services, Inc., New Jersey's oldest and largest health insurer, is a not-for-profit health services corporation.  Horizon Healthcare Services, Inc. serves approximately 3.6 million members and is headquartered in Newark with offices in Wall, Mt. Laurel, and West Trenton.  Horizon Healthcare Services, Inc. provides a wide variety of medical, health and wellness, life insurance, worker compensation and dental insurance products and services, including Medicare and Medicaid products, for local and national businesses and individuals.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT: Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com

Lee Ann Stiller
Director of Business Development
lastiller@corcell.com
812.944.0476


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
2. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
3. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
4. OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass
5. Cord Blood America Reduces "Afford-A-Cord" Program Charges; New Buyers Anticipated
6. Cord Blood America Announces BioCells, Inc., Which it Acquired in 2010, is Opening Office in Miami, Florida and 5 New Offices in Argentina Soon
7. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
8. ThermoGenesis Announces China Customer Implements Cord Blood Products
9. Cord Blood America: Shareholders Approve Common Stock Reverse Split
10. Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression to be Presented at the American Psychiatric Association Annual Meeting
11. Cord Blood America: Court Grants Motion to Dismiss at Lawsuit Aimed at Blocking Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):